Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15448101rdf:typepubmed:Citationlld:pubmed
pubmed-article:15448101lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15448101lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:15448101lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:15448101lifeskim:mentionsumls-concept:C0011854lld:lifeskim
pubmed-article:15448101lifeskim:mentionsumls-concept:C0019764lld:lifeskim
pubmed-article:15448101lifeskim:mentionsumls-concept:C1837352lld:lifeskim
pubmed-article:15448101lifeskim:mentionsumls-concept:C0018591lld:lifeskim
pubmed-article:15448101lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:15448101lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:15448101lifeskim:mentionsumls-concept:C1705242lld:lifeskim
pubmed-article:15448101pubmed:issue10lld:pubmed
pubmed-article:15448101pubmed:dateCreated2004-9-27lld:pubmed
pubmed-article:15448101pubmed:abstractTextTo clarify heterogeneity in Japanese adult-onset type 1 diabetes, we analyzed the HLA-DR and -DQ haplotypes, depending on the clinical phenotype, and compared them with those in childhood-onset type 1 diabetes (CO). The patients in a previously reported Ehime Study were divided into subgroups by the mode of onset of diabetes: 68 acute-onset type 1 diabetic patients (AO) and 28 slowly progressive type 1 diabetic patients (SO). HLA haplotypes were compared with those of 80 CO patients and 190 control subjects. Two major susceptible HLA haplotypes in the Japanese, DRB1*0405-DQB1*0401 (DR4) and DRB1*0901-DQB1*0303 (DR9), were significantly increased in the AO and CO groups, but only DR9 was increased in the SO group. AO subjects had a higher frequency of DR9 than CO subjects. Accordingly, the DR9:DR4 frequency increased with increasing age of onset. Another susceptible haplotype, DRB1*0802-DQB1*0302 (DR8), was involved only in the CO group. Analysis of haplotype combinations revealed that DR4 and DR9 had significant dosage effects on the AO and CO groups (P < 0.0001), but only DR9 had such an effect in the SO group (P < 0.03). These results suggest differences in the contribution of HLA class II haplotypes to susceptibility of type 1 diabetes depending on the clinical phenotype and also indicate that HLA class II haplotypes may be associated with the onset age of type 1 diabetes.lld:pubmed
pubmed-article:15448101pubmed:languageenglld:pubmed
pubmed-article:15448101pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448101pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15448101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448101pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15448101pubmed:statusMEDLINElld:pubmed
pubmed-article:15448101pubmed:monthOctlld:pubmed
pubmed-article:15448101pubmed:issn0012-1797lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:GraffC ACAlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:KainoYukikazu...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:KidaKaichiKlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:EbisuiOsamuOlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:OsawaHaruhiko...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:OnumaHiroshiHlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:NishimiyaTats...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:KatoKenichiKlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:ShimizuIkkiIlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:FujiiYasuhisa...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:OhashiJunJlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:MakinoHideich...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:KawasakiEijiElld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:KonoueEtsushi...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:FujiyamaMasao...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:MuraoSatoshiSlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:TanakaKiyonob...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:TarumiYoshina...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:KondoShioriSlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:TakadaYasuhar...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:TakemotoKojiKlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:OhnoKeizoKlld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:KusunokiYukik...lld:pubmed
pubmed-article:15448101pubmed:authorpubmed-author:TanabeKatsuya...lld:pubmed
pubmed-article:15448101pubmed:issnTypePrintlld:pubmed
pubmed-article:15448101pubmed:volume53lld:pubmed
pubmed-article:15448101pubmed:ownerNLMlld:pubmed
pubmed-article:15448101pubmed:authorsCompleteYlld:pubmed
pubmed-article:15448101pubmed:pagination2684-90lld:pubmed
pubmed-article:15448101pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:meshHeadingpubmed-meshheading:15448101...lld:pubmed
pubmed-article:15448101pubmed:year2004lld:pubmed
pubmed-article:15448101pubmed:articleTitleDifferences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients.lld:pubmed
pubmed-article:15448101pubmed:affiliationMatsuyama Shimin Hospital, Ehime, Japan.lld:pubmed
pubmed-article:15448101pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15448101pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15448101pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3117entrezgene:pubmedpubmed-article:15448101lld:entrezgene
entrez-gene:3119entrezgene:pubmedpubmed-article:15448101lld:entrezgene
entrez-gene:3123entrezgene:pubmedpubmed-article:15448101lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15448101lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15448101lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15448101lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15448101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15448101lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15448101lld:pubmed